However, it is yet to be determined if plasma ACE2 directly helps SARS‐CoV‐2 to replicate, but ACE2 release could cause endothelial dysfunction and hyperinflammation, and consequently, COVID‐19 might get progressively severe.42 This evidence concerns the gene ACE2 and COVID-19.